Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.00058 | 1 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |